1. Ferlay J, Bray F, Pisani P et al. (2001) GLOBOCAN2000: Cancer Incidence, Mortality and Prevalence Worldwide, Version 1.0. IARC Cancer Base No. 5, Lyon, France, IARC Press
2. Shinoda M, Hatooka S, Mori S, et al. (2006) Clinical aspects of multimodality therapy for resectable locoregional esophageal cancer. Ann Thorac Cardiovasc Surg 12(4):234–241
3. Schneider P, Baldus S, Metzger R, et al. (2005) Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer. Ann Surg 242(5):684–692
4. Union Internationale Contre Le Cancer (2002) TNM Classification of Malignant Tumours, 6th Edition, New York, Wiley-Liss
5. Japanese Society for Esophageal Disease. (2001) Guidelines for Clinical and Pathological studies on Carcinoma of the Esophagus, 9th Edition, Tokyo, Kanehara and Co, Ltd